Odylia Therapeutics CEO Featured on Partners4Access Podcast

Scott Dorfman, Odylia Therapeutics CEO, was recently a featured guest on Partners4Access Weekly Podcast.  A recording of the podcast entitled “Rare Disease, Cell and Gene Therapy Weekly Roundup” can be found here.  Produced by Partners4Access, global experts in access for orphan drug, cell and gene therapy and making a difference to those involved in rare diseases, the weekly podcast highlights the most important news and developments and its impact on the orphan drug, cell and gene therapy world. During the session, Dorfman reflects on the mission of the non-profit Odylia, his personal journey and the future in gene therapy development.